Indrayani Biotech: Unaudited Q1 FY27 Results & Board Committee Reconstitution

Indrayani Biotech Ltd announced its unaudited standalone and consolidated financial results for the quarter ended June 30, 2026. The Board of Directors approved these results, which were recommended by the Audit Committee. The statutory auditors provided an unmodified opinion following their review. Additionally, the Board approved the reconstitution of the Audit Committee, Stakeholder Relationship Committee, and Rights Issue Committee, with immediate effect from October 7, 2026. The company will publish the results in newspapers and on its website, as well as the BSE website.